Nahyun Kim

Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled Trial

A. Manikhas, J. Stebbing, V. Moiseyenko, 2023, BioDrugs.

Novel KCNQ4 variants in different functional domains confer genotype- and mechanism-based therapeutics in patients with nonsyndromic hearing loss

W. Park, D. Oh, T. Kang, 2021, Experimental & Molecular Medicine.

Loss of Dact2 alleviates cisplatin-induced nephrotoxicity through regulation of the Igfl-MAPK pathway axis

Y. Park, Dong-Hoon Won, Minhwa Kang, 2023, Cell Biology and Toxicology.